What is NDC 50742-375?

50742-375 is the product NDC for Buprenorphine, Buprenorphine 15 ug/h patch, extended release, listed with the FDA by INGENUS PHARMACEUTICALS, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

INGENUS PHARMACEUTICALS, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Buprenorphine?

53 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Buprenorphine NDC 50742-375 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50742-375Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50742-0375Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50742-375-04	5074203750450742037504	4 POUCH in 1 CARTON (50742-375-04) / 1 PATCH in 1 POUCH / 168 h in 1 PATCHMarketed from Nov 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Buprenorphine
Generic name (nonproprietary): buprenorphine
Active ingredients: Buprenorphine — 15 ug/h
Dosage form: Patch, Extended release
Route: Transdermal
Labeler: INGENUS PHARMACEUTICALS, LLCNDC labeler code 50742
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210272
Marketing start: Nov 1, 2023
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Partial Opioid Agonists (Mechanism)
Identifiers: Product ID 50742-375_5090c42d-8c7d-a0b9-e063-6294a90a925dSPL ID 5090c42d-8c7d-a0b9-e063-6294a90a925dSPL set ID 186e3be6-8bc0-4bb9-96f5-429d53632f45RxCUI 904870, 904876, 904880, 1432969, 1542997UNII 40D3SCR4GZ
Pharmacologic class: Partial Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450742037504 followed by a unit qualifier and the quantity

Package 50742-0375-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 28, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Buprenorphine transdermal system is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate release opioids. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions ( 5.1 )] , reserve opioid analgesics, including buprenorphine transdermal system, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Buprenorphine transde…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50742-375

What is NDC 50742-375?: 50742-375 is the product NDC for Buprenorphine, Buprenorphine 15 ug/h patch, extended release, listed with the FDA by INGENUS PHARMACEUTICALS, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Buprenorphine.
What is the active ingredient?: Buprenorphine.
Who is the labeler?: INGENUS PHARMACEUTICALS, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Buprenorphine?: 53 other product NDCs are listed under this name. See all Buprenorphine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Buprenorphine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Buprenorphine	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Unit Dose Solutions, Inc.	87441-082	87441-0082-01
Buprenorphine	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Unit Dose Solutions, Inc.	87441-011	87441-0011-01
Buprenorphine	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	AvPAK	50268-128	50268-0128-15
Buprenorphine	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	AvPAK	50268-129	50268-0129-15
Buprenorphine	Buprenorphine 5 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1521	03215-1521-04
Buprenorphine	Buprenorphine 7.5 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1522	03215-1522-04
Buprenorphine	Buprenorphine 10 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1523	03215-1523-04
Buprenorphine	Buprenorphine 15 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1524	03215-1524-04
Buprenorphine	Buprenorphine 20 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1525	03215-1525-04
Buprenorphine	Buprenorphine 5 ug/h	Patch, Extended releaseTransdermal	INGENUS PHARMACEUTICALS, LLC	50742-372	50742-0372-04

All 54 Buprenorphine NDCs

Other NDCs under ANDA 210272

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210272
Product	Strength	Form · route	Labeler	Product NDC
Buprenorphine	Buprenorphine 5 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1521
Buprenorphine	Buprenorphine 7.5 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1522
Buprenorphine	Buprenorphine 10 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1523
Buprenorphine	Buprenorphine 15 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1524
Buprenorphine	Buprenorphine 20 ug/h	Patch, Extended releaseTransdermal	Aveva Drug Delivery Systems Inc.	3215-1525
Buprenorphine	Buprenorphine 5 ug/h	Patch, Extended releaseTransdermal	INGENUS PHARMACEUTICALS, LLC	50742-372
Buprenorphine	Buprenorphine 7.5 ug/h	Patch, Extended releaseTransdermal	INGENUS PHARMACEUTICALS, LLC	50742-373
Buprenorphine	Buprenorphine 10 ug/h	Patch, Extended releaseTransdermal	INGENUS PHARMACEUTICALS, LLC	50742-374
Buprenorphine	Buprenorphine 20 ug/h	Patch, Extended releaseTransdermal	INGENUS PHARMACEUTICALS, LLC	50742-376